Skip to content
Universität Bonn
Universitätsklinikum Bonn


Epigenetik der Immuncheckpoint-Gene

  • Braun M, Aguilera AR, Sundarrajan A, Corvino D, Stannard K, Krumeich S, Das I, Lima LG, Meza Guzman LG, Li K, Li R, Salim N, Jorge MV, Ham S, Kelly G, Vari F, Lepletier A, Raghavendra A, Pearson S, Madore J, Jacquelin S, Effern M, Quine B, Koufariotis LT, Casey M, Nakamura K, Seo EY, Hölzel M, Geyer M, Kristiansen G, Taheri T, Ahern E, Hughes BGM, Wilmott JS, Long GV, Scolyer RA, Batstone MD, Landsberg J, Dietrich D, Pop OT, Flatz L, Dougall WC, Veillette A, Nicholson SE, Möller A, Johnston RJ, Martinet L, Smyth MJ, Bald T:
    CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells.
    Immunity 2020, 53(4):805-823.e15 (JIF: 22,553)
  • Fröhlich A, Sirokay J, Fietz S, Vogt TJ, Dietrich J, Zarbl R, Florin M, Kuster P, Saavedra G, Valladolid SR, Hoffmann F, Flatz L, Ring SS, Golletz C, Pietsch T, Strieth S, Brossart P, Gielen GH, Kristiansen G, Bootz F, Landsberg J, Dietrich D:
    Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.
    EBioMedicine 2020, 59:102962 (JIF: 5.736)
  • Vos L, Dietrich J, Strieth S, Bootz F, Dietrich D, Franzen A:
    PD-1, CTLA4, PD-L1 and PD-L2 DNA methylation in papillary thyroid carcinoma.
    Immunotherapy 2020, 12(12):903-920 (JIF: 2.964)
  • Hoffmann F, Zarbl R, Niebel D, Sirokay J, Fröhlich A, Posch C, Holderried TAW, Brossart P, Saavedra G, Kuster P, Strieth S, Gielen GH, Ring SS, Dietrich J, Pietsch T, Flatz L, Kristiansen G, Landsberg J, Dietrich D:
    Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma.
    Clin Epigenetics 2020, 12(1):94 (JIF: 5.028)
  • Klümper N, Ralser DJ, Bawden EG, Landsberg J, Zarbl R, Kristiansen G, Toma M, Ritter M, Hölzel M, Ellinger J, Dietrich D:
    LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma.
    J Immunother Cancer 2020, 8(1). pii: e000552 (JIF: 8,728)
  • Fröhlich A, Loick S, Bawden EG, Fietz S, Dietrich J, Diekmann E, Saavedra G, Fröhlich H, Niebel D, Sirokay J, Zarbl R, Gielen GH, Kristiansen G, Bootz F, Landsberg J, Dietrich D:
    Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
    EBioMedicine 2020, 52:102647 (JIF: 6,490)
  • de Vos L, Grünwald I, Bawden EG, Dietrich J, Scheckenbach K, Wiek C, Zarbl R, Bootz F, Landsberg J, Dietrich D:
    The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas.
    Epigenetics 2020, 21:1-18 (JIF: 4,173)
  • Holderried TAW, de Vos L, Bawden EG, Vogt TJ, Dietrich J, Zarbl R, Bootz F, Kristiansen G, Brossart P, Landsberg J, Dietrich D:
    Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma.
    Clin Epigenetics 2019, 11(1):161 (JIF: 5,496)
  • Sailer V, Sailer U, Bawden EG, Zarbl R, Wiek C, Vogt TJ, Dietrich J, Loick S, Grünwald I, Toma M, Golletz C, Gerstner A, Kristiansen G, Bootz F, Scheckenbach K, Landsberg J, Dietrich D:
    DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients' survival, immune cell infiltrates, mutational load, and interferon ã signature.
    EBioMedicine 2019, 48:341-352 (JIF: 6,490)
  • Vogt TJ, Gevensleben H, Dietrich J, Kristiansen G, Bootz F, Landsberg J, Goltz D, Dietrich D:
    Detailed analysis of adenosine A2a receptor (ADORA2A) and CD73 (5'-nucleotidase, ecto, NT5E) methylation and gene expression in head and neck squamous cell carcinoma patients. Oncoimmunology 2018, 7(8): e1452579 (JIF: 5,333)
  • Goltz D, Gevensleben H, Vogt TJ, Dietrich J, Golletz C, Bootz F, Kristiansen G, Landsberg J, Dietrich D:
    CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patients. JCI Insight 2018, 3(13) (JIF: 6,014)
  • Röver LK, Gevensleben H, Dietrich J, Bootz F, Landsberg J, Goltz D, Dietrich D. PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations.
    EBioMedicine 2018, 28:97-104 (JIF: 6,490)
  • Goltz D, Gevensleben H, Grünen S, Dietrich J, Kristiansen G, Landsberg J, Dietrich D:
    PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia.
    Leukemia 2017, 31(3):738-743 (JIF: 9,944)
  • Goltz D, Gevensleben H, Dietrich J, Schroeck F, de Vos L, Droege F, Kristiansen G, Schroeck A, Landsberg J, Bootz F, Dietrich D:
    PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients.
    Oncotarget 2017, 8(25):41011-41020 (JIF: 5,168)
  • Franzen A, Vogt TJ, Müller T, Dietrich J, Schröck A, Golletz C, Brossart P, Bootz F, Landsberg J, Kristiansen G, Dietrich D:
    PD-L1 (CD274) and PD-L2 (PDCD1LG2) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas.
    Oncotarget 2017, 9(1):641-650 (JIF: 5,168)

Zielgerichtete Tumortherapie

  • Göke F, Franzen A, Hinz TK, Marek LA, Yoon P, Sharma R, Bode M, von Maessenhausen A, Lankat-Buttgereit B, Göke A, Golletz C, Kirsten R, Boehm D, Vogel W, Kleczko EK, Eagles JR, Hirsch FR, Van Bremen T, Bootz F, Schroeck A, Kim J, Tan AC, Jimeno A, Heasley LE, Perner S:
    FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers.
    Clin Cancer Res 2015, 21(19):4356-64 (JIF: 9,618)
  • Gellrich D, Becker S, Strieth S:
    Static magnetic fields increase tumor microvessel leakiness and improve antitumoral efficacy in combination with paclitaxel.
    Cancer Lett 2014, 343:107-14 (JIF: 6,375)
  • Göke F, Franzen A, Menon R, Goltz D, Kirsten R, Boehm D, Vogel W, Göke A, Scheble V, Ellinger J, Gerigk U, Fend F, Wagner P, Schroeck A, Perner S:
    Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors.
    Chest 2012,142(4):1020-1026 (JIF: 9,657)
  • Strieth S, Eichhorn ME, Werner A, Sauer B, Teifel M, Michaelis U, Berghaus A, Dellian M:
    Liposomal paclitaxel increases tumor microvessel leakiness and improves therapeutic efficacy in combination with cisplatin.
    Clin Cancer Res 2008, 14: 4603-11 (JIF: 9,618)
  • Strieth S*, Nussbaum CF*, Eichhorn ME, Fuhrmann M, Teifel M, Michaelis U, Berghaus A, Dellian M:
    Tumor-selective vessel occlusions by platelets after vascular targeting chemotherapy using paclitaxel encapsulated in cationic liposomes. [*contributed equally to this study]
    Int J Cancer 2008, 122:452-60 (JIF: 6,513)
  • Strieth S, Eichhorn ME, Sutter A, Jonczyk A, Berghaus A, Dellian M:
    Anti-angiogenic combination tumor therapy blocking av-integrins and VEGF-receptor-2 increases therapeutic effects in vivo. Int J Cancer 2006, 119:423-431 (JIF: 6,513)
  • Strieth S, Eichhorn ME, Sauer B, Schulze B, Teifel M, Michaelis U, Dellian M: Neovascular targeting chemotherapy: paclitaxel encapsulated in cationic liposomes impairs functional tumor microvasculature.
    Int J Cancer 2004, 110:117-124 (JIF: 6,513)
  • Schmitt-Sody M*, Strieth S*, Krasnici S, Sauer B, Schulze, Teifel M, Michaelis U, Naujoks K, Dellian M:
    Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumor efficacy. [*contributed equally to this study]
    Clin Cancer Res 2003, 9:2335-2341 (JIF: 9,618)
  • Strieth S, Hartschuh H, Pilz L, Fusenig NE: Angiogenic switch occurs late in squamous cell carcinomas of human skin.
    Br J Cancer 2000, 82: 591-600 (JIF: 6,176)

Liquid Biopsy

  • de Vos L, Jung M, Koerber RM, Bawden EG, Holderried TAW, Dietrich J, Bootz F, Brossart P, Kristiansen G, Dietrich D:
    Treatment response monitoring in patients with advanced malignancies using cell-free SHOX2 and SEPT9 DNA methylation in blood: An observational prospective study.
    J Mol Diagn 2020, pii: S1525-1578(20)30299-3 (JIF: 4,426)
  • Jung M, Ellinger J, Gevensleben H, Syring I, Lüders C, de Vos L, Pützer S, Bootz F, Landsberg J, Kristiansen G, Dietrich D:
    Cell-Free SHOX2 DNA Methylation in Blood as a Molecular Staging Parameter for Risk Stratification in Renal Cell Carcinoma Patients: A Prospective Observational Cohort Study.
    Clin Chem 2019, 65(4):559-568 (JIF: 6,891)
  • Bergheim J, Semaan A, Gevensleben H, Groening S, Knoblich A, Dietrich J, Weber J, Kalff JC, Bootz F, Kristiansen G, Dietrich D:
    Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
    Br J Cancer 2018, 118(9):1217-1228 (JIF: 5,416)
  • Schröck A, Leisse A, de Vos L, Gevensleben H, Dröge F, Franzen A, Wachendörfer M, Schröck F, Ellinger J, Teschke M, Wilhelm-Buchstab T, Landsberg J, Holdenrieder S, Hartmann G, Field JK, Bootz F, Kristiansen G, Dietrich D:
    Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
    Clin Chem 2017, 63(7):1288-1296 (JIF: 6,891)
  • Kneip C, Schmidt B, Seegebarth A, Weickmann S, Fleischhacker M, Liebenberg V, Field JK, Dietrich D:
    SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma.
    J Thorac Oncol 2011, 6(10):1632-8 (JIF: 12,460)


  • Joiko J, Bohnert A, Strieth S, Soli SD, Rader T:
    The German Hearing in Noise Test.
    Int J Audiol, online ahead of print (JIF: 1.759)
  • Heinrich UR, Schmidtmann I, Meuser R, Ernst BP, Wünsch D, Siemer S, Gribko A, Stauber RH, Strieth S:
    Early Alterations of Endothelial Nitric Oxide Synthase Expression Patterns in the Guinea Pig Cochlea After Noise Exposure.
    J Histochem Cytochem 2019, 67(11):845-855 (JIF: 2,730)
  • Plesch J, Ernst BP, Strieth S, Rader T: A psychoacoustic application for the adjustment of electrical hearing thresholds in cochlear implant patients.
    PLoS One 2019, 14(10):e0223625 (JIF: 2,776)
  • Heinrich UR, Strieth S, Schmidtmann I, Stauber R, Helling K:
    Dexamethasone prevents hearing loss by restoring glucocorticoid receptor(GR)-expression in the lateral wall of the guinea pig cochlea.
    Laryngoscope 2016; 126:E29-34. (JIF: 2,471)
  • Heinrich UR, Schmidtmann I, Strieth S, Helling K:
    Cell-specific accumulation patterns of gentamicin in the guinea pig cochlea.
    Hear Res 2015; 326:40-8. (JIF: 2,906)
  • Arpornchayanon W, Canis M, Ihler F, Settevendemie C, Strieth S:
    TNF-α inhibition using etanercept prevents noise-induced hearing loss by improvement of cochlear blood flow in vivo.
    Int J Audiol 2013, 52:545-52. (JIF: 1,116)
  • Arpornchayanon W*, Canis M*, Suckfuell M, Ihler F, Olzowy B, Strieth S: Modeling the measurements of cochlear microcirculation and hearing function after loud noise. [*contributed equally to this study]
    Otolaryngol Head Neck Surg 2011, 145:463-9 (JIF: 2,276)
  • Scherer EQ, Yang J, Canis M, Reimann K, Ivanov K, Diehl CD, Backx PH, Wier WG, Strieth S, Wangemann P, Voigtlaender-Bolz J, Lidington D, Bolz SS: Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling.
    Stroke 2010, 41:2618-24 (JIF: 6,032)


  • Siemer S, Westmeier D, Barz M, Eckrich J, Wünsch D, Seckert C, Thyssen C, Schilling O, Hasenberg M, Pang C, Docter D, Knauer SK, Stauber RH, Strieth S:
    Biomolecule-corona formation confers resistance of bacteria to nanoparticle-induced killing: Implications for the design of improved nanoantibiotics. Biomaterials 2019,192:551-559 (JIF: 10,237)
  • Hessenauer MET, Lauber K, Zuchtriegel G, Uhl B, Hussain T, Canis M, Strieth S, Berghaus A, Reichel CA:
    Vitronectin promotes the vascularization of porous Polyethylene biomaterials. Acta Biomater 2018, 82:24-33. (JIF: 6,319)
  • Reichel CA, Hessenauer ME, Pflieger K, Rehberg M, Kanse SM, Zahler S, Krombach F, Berghaus A, Strieth S:
    Components of the Plasminogen Activation System Promote Engraftment of Porous Polyethylene Biomaterial via Common and Distinct Effects.
    PLoS One 2015; 10(2): e0116883 (JIF: 2,806)

Klinische Studien

  • Strieth S, Ernst BP, Both I, Hirth D, Pfisterer LN, Künzel J, Eder K: Randomized controlled single-blinded clinical trial of functional voice outcome after vascular targeting KTP-laser microsurgery of early laryngeal cancer.
    Head Neck 2019,41:899-907 (JIF: 3,376)
  • Ernst BP, Hodeib M, Strieth S, Künzel J, Bischof F, Hackenberg B, Huppertz T, Weber V, Bahr K, Eckrich J, Hagemann J, Engelbarts M, Froelich MF, Solbach P, Linke R, Matthias C, Sommer WH, Becker S:
    Structured reporting of head and neck ultrasound examinations.
    BMC Med Imaging 2019, 19:25 (JIF: 1,622)
  • Send T, Tuleta I, Koppen T, Thiesler T, Bertlich M, Bootz F, Jakob M: Sarcoidosis of the paranasal sinuses
    European Archives of Oto-Rhino-Laryngology 2019, 276(7):1969-1974 (JIF: 1,750)
  • Send T, Bertlich M, Eichhorn K, Bootz F, Jakob M: Management and follow-up results of salivary fistulas treated with botulinumtoxin
    Laryngoscope 2019 Feb;129(2):403-408 (JIF: 2,442)
  • Freytag M, Herrlinger U, Hauser S, Bauernfeind F, Gonzalez-Carmona M, Landsberg J, Buermann J,Vatter H, Holderried T, Send T, Schumacher M, Koscielny A, Feldmann G, Skowasch D, Heine M, Schäfer N, Funke B, Neumann M,Schmidt-Wolf I:
    Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome: A matched pair analysis
    BMC Cancer 2019, 20(1):355 (JIF: 3,288)
  • Rader T, Bohnert A, Matthias C, Koutsimpelas D, Kainz MA, Strieth S:
    Hearing preservation in children with electric-acoustic stimulation after cochlear implantation: Outcome after electrode insertion with minimal insertion trauma.
    HNO 2018, 66 (Suppl 2):56-62. (JIF: 0,723)
  • Gabrielpillai J, Burck I, Baumann U, Stöver T, Helbig S:
    Incidence for Tip Foldover During Cochlea Implantation. Otol Neurotol. 2018, 39(9):1115-1121 (JIF: 2.063)
  • Eichhorn K, Westphal R, Rilk M,Last C, Bootz F, Wahl F, Jakob M, Send T: Robot-assisted endoscope guidance versus manual endoscope guidance in functional endonasal sinus surgery (FESS).
    Acta Otolaryngol 2017,137(10):1090-1095 (JIF 1,286)
  • Strieth S, Dunau C, Michaelis U, Jäger, L, Gellrich D, Wollenberg B, Dellian M: Phase I/II clinical study on safety and antivascular effects of paclitaxel encapsulated in cationic liposomes for targeted therapy in advanced head and neck cancer.
    Head Neck 2014, 36:976-84. (JIF: 3,376)
  • Strieth S, Siedek V*, Rytvina M, Gürkov R, Berghaus A, Clevert DA*: Dynamic contrast-enhanced ultrasound for differential diagnosis of submandibular gland disease. [*contributed equally to this study]
    Eur Arch Otorhinolaryngol 2014, 271:163-9. (JIF: 1,660)
  • Strieth S, Dunau C, Kolbow K, Knuechel R, Michaelis U, Ledderose H, Eichhorn ME, Strelczyk D, Tschiesner U, Wollenberg B, Dellian M:
    Phase I clinical study of vascular targeting fluorescent cationic liposomes in head and neck cancer.
    Eur Arch Otorhinolaryngol 2013, 270:1481-7. (JIF: 1,660)
  • Suckfuell M, Canis M, Strieth S, Scherer H, Haisch H:
    Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: a prospective randomized phase-I/II study.
    Acta Otolaryngol 2007, 127:938-42. (JIF: 1,116)


  • Strieth S, Hagemann J, Hess M:
    [Angiolytic laser applications for the larynx : Phonosurgical concepts for transoral laser microsurgery].
    HNO 2020, 68:59-68 (JIF: 1.000)

  • Dietrich D:
    [FGFR-targeted therapy in head and neck carcinomas].
    HNO 2020, online ahead of print (JIF: 1.000)

  • Stöver T, Dazert S, Hoffmann TK, Plontke SK, Ambrosch P, Arens C, Betz C, Beutner D, Bohr C, Bruchhage KL, Canis M, Dietz A, Guntinas-Lichius O, Hagen R, Hosemann W, Iro H, Klussmann JP, Knopf A, Kramer S, Lang S, Leinung M, Lenarz T, Löwenheim H, Matthias C, Mlynski R, Olze H, Park J, Plinkert P, Radeloff A, Rotter N, Rudack C, Bozzato A, Schipper J, Schrader M, Strieth S, Stuck BA, Volkenstein S, Westhofen M, Wolf G, Wollenberg B, Zahnert T, Zenk J:
    [Effects of the SARS-CoV-2 pandemic on the otorhinolaryngology university hospitals in the field of medical care].
    Laryngorhinootologie 2020, 99(10):694-706  (JIF: 0.922)

  • Klimek L, Bachert C, Pfaar O , Sven Becker S , Bieber T , Brehler R , Buhl  R , Casper  I , Adam Chaker  A , Wolfgang Czech  W , Jörg Fischer J , Thomas Fuchs T , Michael Gerstlauer M , Karl Hörmann K , Thilo Jakob T , Kirsten Jung K , Kopp MV, Mahler V , Merk H , Norbert Mülleneisen  N , Katja Nemat  K , Uta Rabe U, Johannes Ring  J , Joachim Saloga  J , Wolfgang Schlenter  W , Carsten Schmidt-Weber  C , Holger Seyfarth  H , Annette Sperl  A , Thomas Spindler  T , Petra Staubach  P , Strieth  S , Treudler  R , Vogelberg  C, Wallrafen A , Wehrmann  W , Wrede  H , Zuberbier T, Bedbrook A , Canonica  GW , Cardona  V, Casale  TB , Czarlewski W , Fokkens  WJ , Hamelmann  E, Jutel  M , Larenas-Linnemann D, Mullol J , Papadopoulos NG , Toppila-Salmi S , Werfel  T , Bousquet J:
    ARIA guideline 2019: treatment of allergic rhinitis in the German health system
    Allergol Select 2019, 30,3(1): 22-50

  • Klimek L, Chaker AM, Casper I, Sperl A, Strieth S, Mösges R.
    [Therapy of Allergies and Allergy Immunotherapy in Children].
    Laryngorhinootologie 2020, 99(1):56-66 (JIF: 0.922)

  • Bootz F, Franzen A:
    [Surgical therapy of oropharyngeal cancer-state of the art].
    HNO 2020, 68:657-661 (JIF: 1.000)

  • Hackenberg B, Große-Büning S, Hammes S, Strieth S:
    [Complications of cosmetic piercings and tattoos in the head and neck region].
    HNO 2020, 68:131-140  (JIF: 1.000)

  • Leggewie B, Zimmermann A, Strieth S, Gouveris H:
    [Systemic and local therapy options for sudden sensorineural hearing loss in diabetics].
    HNO 2019 67:639-648 (JIF: 0,914)

  • Stauber RH Siemer S; Becker S, Ding GB; Strieth S, Knauer S:
    Small meets smaller: effects of nanomaterials on microbial biology, pathology, and ecology.
    ACS Nano 2018, 12:6351-6359 (JIF: 13,903)

  • Beltz A, Gösswein D, Zimmer S, Stauber RH, Hagemann J, Strieth S, Matthias C, Künzel J:
    [Staging of oropharyngeal carcinomas: New TNM classification as a challenge for head and neck cancer centers].
    HNO 2018, 66(5):375-3 (JIF: 0,914)

  • Künzel J, Strieth S, Wirth G, Bozzato A:
    Ultrasound in the re-staging of cervical metastases after chemoradiotherapy for head and neck cancer.
    Ultraschall in Med 2018, 39:659-666 (JIF: 4,613)

  • Ernst BP, Strieth S:
    [Recent developments towards molecularly targeted therapy of head and neck cancer]
    Laryngorhinootologie 2017, 96:185-98 (JIF: 0,732)

  • Künzel J, Bozzato A, Strieth S:
    [Follow-up ultrasound of head and neck cancer]
    HNO 2017, 65:939-52 (JIF: 0,914)

  • Beltz A, Gösswein D, Zimmer S, Stauber RH, Hagemann J, Strieth S, Matthias C, Künzel J:
    [Staging of oropharyngeal carcinomas: New TNM classification as a challenge for head and neck cancer centers].
    HNO 2018, 66(5):375-3 (JIF: 0,723)

  • Künzel J, Strieth S, Wirth G, Bozzato A:
    Ultrasound in the Re-Staging of Cervical Metastases after Chemoradiotherapy for Head and Neck cancer.
    Ultraschall in Med 2018 (JIF: 3,892)

  • Künzel J, Bozzato A, Strieth S:
    [Follow-up ultrasound of head and neck cancer]
    HNO 2017, 65:939-52 (JIF: 0,723)

  • Docter D, Strieth S, Westmeier D, Hayden O, Gao M, Knauer SK, Stauber RH:
    No king without a crown - impact of the nanomaterial-protein corona on nanobiomedicine.
    Nanomedicine (Lond) 2015 Feb;10: 503-19 (JIF: 5,720)

  • Strieth S, Stöver T:
    [Functional soft-palate reconstruction with radial forearm free flaps]
    Laryngorhinootologie 2013, 92:347-58 (JIF: 0,732)

  • Strieth S:
    [Tissue engineering using porous polyethylene implants]
    HNO 2013, 61(3):211-6 (JIF: 0,723)

  • Eichhorn ME, Strieth S, Dellian M:
    Anti-vascular tumor therapy: Recent advances, pitfalls and clinical perspectives.
    Drug Resist Updat 2004, 7: 125-138 (JIF: 10,906)

  • Dellian M, Eichhorn ME, Strieth S:
    [Antivascular strategies – a new concept for diagnosis and therapy of head and neck cancer. A review]
    Laryngorhinootologie 2002, 81:509-515 (JIF: 0,732)


Information gemäß § 6 Medizinprodukte-Betreiberverordnung "Beauftragter für Medizinproduktesicherheit"

Sehr geehrte Damen und Herren,

gemäß § 6 Medizinprodukte-Betreiberverordnung steht Ihnen das Universitätsklinikum Bonn im Zusammenhang mit Meldungen über Risiken von Medizinprodukten, Informationen zu Rückrufen oder Warn- und Sicherheitshinweisen sowie bei der Umsetzung von notwendigen korrektiven Maßnahmen unter folgender E-Mailadresse zur Verfügung: Enable JavaScript to view protected content.

Diese E-Mailadresse richtet sich vorzugsweise an Kontaktpersonen von Behörden, Herstellern und Vertreibern von Medizinprodukten.